デフォルト表紙
市場調査レポート
商品コード
1663037

左心房付属器閉鎖装置の市場規模、シェア、成長分析:製品別、手技別、エンドユーザー別、地域別 - 産業予測 2025~2032年

Left Atrial Appendage Closure Devices Market Size, Share, and Growth Analysis, By Product (Endocardial LAA devices, Epicardial LAA devices), By Procedure (Percutaneous, Surgical), By End User, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 184 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
左心房付属器閉鎖装置の市場規模、シェア、成長分析:製品別、手技別、エンドユーザー別、地域別 - 産業予測 2025~2032年
出版日: 2025年02月21日
発行: SkyQuest
ページ情報: 英文 184 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

左心房付属器閉鎖装置 2023年の市場規模は11億2,000万米ドルで、2024年の13億6,000万米ドルから2032年には63億7,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは21.3%で成長する見通しです。

同市場は、主に不健康な食生活、喫煙、不摂生なライフスタイルなどの要因に影響される心房細動の発症率の上昇を原動力とする需要の顕著な上昇を目の当たりにしています。この成長は、消費者行動の変化、ヘルスケアへのアクセス強化、心血管問題に罹患しやすい高齢化によってさらに促進されます。さらに、電気生理学的処置の分野は、介入方法と診断能力の両方を強化する技術的進歩に支えられ、大きなビジネスチャンスをもたらしています。インプラントや手技の安全性と有効性における著しい進歩は、先進国市場の情勢を一変させるだけでなく、新興国市場でも支持を集めており、今後数年間の業界成長の有望な見通しを示しています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 規制情勢
  • ケーススタディ
  • 技術の進歩

左心房付属器閉鎖装置市場規模:製品別& CAGR(2025-2032)

  • 市場概要
  • 心内膜LAAデバイス
  • 心外膜LAAデバイス

左心房付属器閉鎖装置市場規模:手技別& CAGR(2025-2032)

  • 市場概要
  • 経皮
  • 外科手術

左心房付属器閉鎖装置市場規模:エンドユーザー別& CAGR(2025-2032)

  • 市場概要
  • 病院
  • 外来手術センター
  • その他

左心房付属器閉鎖装置市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Boston Scientific Corporation(USA)
  • Abbott Laboratories(USA)
  • AtriCure, Inc.(USA)
  • Johnson & Johnson(USA)
  • Lifetech Scientific(China)
  • Occlutech International AB(Sweden)
  • Artio Medical(USA)
  • Cardia, Inc.(USA)
  • Lepu Medical Technology Co., Ltd.(China)
  • Conformal Medical(USA)
  • Nanjing YDB Technology(China)
  • Shanghai Push Medical Device Technology(China)
  • Aegis Medical Group(USA)
  • Acutus Medical, Inc.(USA)
  • FEops(Belgium)

結論と提言

目次
Product Code: SQMIG35A2586

Left Atrial Appendage Closure Devices Market size was valued at USD 1.12 billion in 2023 and is poised to grow from USD 1.36 billion in 2024 to USD 6.37 billion by 2032, growing at a CAGR of 21.3% during the forecast period (2025-2032).

The market is witnessing a notable uptick in demand driven by the rising incidence of atrial fibrillation, primarily influenced by factors such as unhealthy diets, smoking, and inactive lifestyles. This growth is further fueled by changing consumer behaviors, enhanced healthcare access, and an aging demographic more susceptible to cardiovascular issues. Additionally, the field of electrophysiology procedures presents significant opportunities, supported by technological progress that enhances both intervention methods and diagnostic capabilities. Significant advancements in the safety and effectiveness of implants and procedures are not only transforming the landscape in developed markets but are also gaining traction in developing regions, presenting a promising outlook for industry growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Left Atrial Appendage Closure Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Left Atrial Appendage Closure Devices Market Segments Analysis

Global Left Atrial Appendage Closure Devices Market is segmented by Product, Procedure, End User and region. Based on Product, the market is segmented into Endocardial LAA devices and Epicardial LAA devices. Based on Procedure, the market is segmented into Percutaneous and Surgical. Based on End User, the market is segmented into Hospitals, Ambulatory surgical centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Left Atrial Appendage Closure Devices Market

The rising incidence of atrial fibrillation, which poses a considerable risk for strokes and various cardiovascular issues, serves as a key catalyst for the growing utilization of left atrial appendage (LAA) closure devices. As more individuals are diagnosed with this condition, the demand for effective solutions to mitigate associated health risks increases. This trend highlights the urgency for medical advancements in the field, encouraging healthcare providers to adopt LAA closure devices as a preventive measure. Consequently, the surge in atrial fibrillation cases is expected to play a crucial role in propelling the LAA closure devices market forward.

Restraints in the Left Atrial Appendage Closure Devices Market

The intricate nature of Left Atrial Appendage (LAA) closure procedures, coupled with potential complications such as device migration and periprocedural bleeding, poses significant challenges that may hinder their widespread adoption. This is especially true for less-experienced healthcare providers who may feel apprehensive about performing these complex interventions. The risk of complications can lead to concerns about patient safety, thereby deterring practitioners from incorporating LAA closure devices into their treatment regimens. Consequently, the overall growth of the market for these devices could be limited due to the steep learning curve associated with mastering the necessary techniques and managing potential adverse outcomes.

Market Trends of the Left Atrial Appendage Closure Devices Market

The Left Atrial Appendage (LAA) Closure Devices market is witnessing a significant trend towards minimally invasive procedures, reflecting a broader shift in cardiovascular care. Healthcare providers are increasingly adopting LAA closure techniques that minimize the need for open-heart surgeries, favoring transcatheter approaches that offer less trauma, faster recovery, and shorter hospital stays for patients. This transition is not only improving patient outcomes and satisfaction but also driving innovation and competition within the market. As awareness of the benefits of these minimally invasive interventions grows, the demand for advanced LAA closure devices is expected to rise, shaping the future of cardiac treatments.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies
  • Technological Advancement

Global Left Atrial Appendage Closure Devices Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Endocardial LAA devices
  • Epicardial LAA devices

Global Left Atrial Appendage Closure Devices Market Size by Procedure & CAGR (2025-2032)

  • Market Overview
  • Percutaneous
  • Surgical

Global Left Atrial Appendage Closure Devices Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Ambulatory surgical centers
  • Others

Global Left Atrial Appendage Closure Devices Market Size & CAGR (2025-2032)

  • North America (Product, Procedure, End User)
    • US
    • Canada
  • Europe (Product, Procedure, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Procedure, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Procedure, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Procedure, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AtriCure, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lifetech Scientific (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Occlutech International AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Artio Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardia, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lepu Medical Technology Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Conformal Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nanjing YDB Technology (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shanghai Push Medical Device Technology (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aegis Medical Group (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Acutus Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FEops (Belgium)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations